Pathophysiological aspects of cellular pyridine nucleotide metabolism: Focus on the vascular endothelium. Review

Acta Physiologica Hungarica

Volumn 90, Issue 3, 2003, Pages 175-193

  Szabó, Csaba ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INOTEK CORPORATION   (United States)

Author keywords

DNA; Endothelium; Free radicals; Inflammation; Mitochondria; NADPH oxidase; Nitric oxide; Oxidants; Poly(ADP ribose) polymerase; Poly(ADP ribose) synthetase; Pyridine nucleotides; Reperfusion; Shock; Superoxide

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINO ACID; BACTERIAL TOXIN; CALCIUM; DNA; FREE RADICAL; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PYRIDINE NUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE;

CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CATALYSIS; CELL DAMAGE; CELL VIABILITY; HOMEOSTASIS; HUMAN; INFLAMMATION; MITOCHONDRION; NONHUMAN; NUCLEOTIDE METABOLISM; OXIDATIVE STRESS; PROTEIN MODIFICATION; REPERFUSION INJURY; REVIEW; SHOCK; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ADP RIBOSE TRANSFERASES; ANIMALS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; MODELS, BIOLOGICAL; NAD; NADP; NADPH OXIDASE; POLY(ADP-RIBOSE) POLYMERASES;

EID: 0142104841     PISSN: 0231424X     EISSN: None     Source Type: Journal    
DOI: 10.1556/APhysiol.90.2003.3.1     Document Type: Review

References (103)

1. Affar el B, Shah RG, Dallaire AK, Castonguay V, Shah GM: Role of poly(ADP-ribose) polymerase in rapid intracellular acidification induced by alkylating DNA damage. Proc. Natl. Acad. Sci. USA 99, 245-50 (2002)
2. Al-Mehdi AB, Zhao G, Dodia C, Tozawa K, Costa K, Muzykantov V, Ross C, Blecha F, Dinauer M, Fisher AB: Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. Circ. Res. 83, 730-7 (1998)
3. Andreoli SP: Mechanisms of endothelial cell ATP depletion after oxidant injury. Pediatr. Res. 25, 97-101 (1989)
4. Anggard EE: The endothelium - the body's largest endocrine gland? J. Endocrinol. 127, 371-5 (1990)
5. Babior BM: The NADPH oxidase of endothelial cells. IUBMB Life 50, 267-9 (2000)
6. Bai P, Bakondi E, Szabo E, Gergely P, Szabo C, Virag L: Partial protection by poly(ADP-ribose) polymerase inhibitors from nitroxyl-induced cytotoxity in thymocytes. Free Radic. Biol. Med. 31, 1616-23 (2001)
7. Berry C, Brosnan MJ, Fennell J, Hamilton CA, Dominiczak AF: Oxidative stress and vascular damage in hypertension. Curr. Opin. Nephrol. Hypertens. 10, 247-55 (2001)
8. Blundell G, Jones BG, Rose FA, Tudball N: Homocysteine mediated endothelial cell toxicity and its amelioration. Atherosclerosis 122, 163-72 (1996)
9. Christ M, Bauersachs J, Liebetrau C, Heck M, Gunther A, Wehling M: Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin. Diabetes 51, 2648-52 (2002)
10. Cole KK, Perez-Polo JR: Poly(ADP-ribose) polymerase inhibition prevents both apoptotic-like delayed neuronal death and necrosis after H(2)O(2) injury. J. Neurochem. 82, 19-29 (2002)
11. Cuzzocrea S, Zingarelli B, Caputi AP: Role of peroxynitrite and poly (ADP-ribosyl) synthetase activation in cardiovascular derangement induced by zymosan in the rat. Life Sci. 63, 923-33 (1998)
12. Cuzzocrea S, Zingarelli B, Costantino G, Szabó A, Salzman AL, Caputi AP, Szabó C: Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br. J. Pharmacol. 121, 1065-74 (1997)
13. Du L, Zhang X, Han YY, Burke NA, Kochanek PM, Watkins SC, Graham SH, Carcillo JA, Szabó C, Clark RS: Intra-mitochondrial poly-ADP-ribosylation contributes to NAD+ depletion and cell death induced by oxidative stress. J. Biol. Chem. 278, 18426-18433 (2003)
14. Di Lisa F, Ziegler M: Pathophysiological relevance of mitochondria in NAD(+) metabolism. FEBS Lett. 492, 4-8 (2001)
15. Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, Pieper A, Wang ZQ, Dawson TM, Snyder SH, Dawson VL: Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. 3, 1089-95 (1997)
16. Fukuda Y, Teragawa H, Matsuda K, Yamagata T, Matsuura H, Chayama K: Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia. Heart 87, 264-9 (2002)
17. Garavaglia S, D'Angelo I, Emanuelli M, Carnevali F, Pierella F, Magni G, Rizzi M: Structure of human NMN adenylyltransferase. A key nuclear enzyme for NAD homeostasis. J. Biol. Chem. 277, 8524-30 (2002)
18. Goldstein S, Czapski G: Reactivity of peroxynitrite versus simultaneous generation of (*)NO and O(2)(*)(-) toward NADH. Chem, Res. Toxicol. 13, 736-41 (2000)
19. Gorlach A, Kietzmann T, Hess J: Redox signaling through NADPH oxidases: involvement in vascular proliferation and coagulation. Ann. NY Acad. Sci. 973, 505-7 (2002)
20. Grant RS, Passey R, Matanovic G, Smythe G, Kapoor V: Evidence for increased de novo synthesis of NAD in immune-activated RAW264.7 macrophages: a self-protective mechanism? Arch. Biochem. Biophys. 372, 1-7 (1999)
21. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M: Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol. 20, 2175-83 (2000)
22. Guse AH: Cyclic ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP): novel regulators of Ca2+-signaling and cell function. Curr. Mol. Med. 2, 273-82 (2002)
23. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ramatunga C, Pillai R, Channon KM: Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105, 1656-62 (2002)
24. Haag F, Koch-Nolte F: Endogenous relatives of ADP-ribosylating bacterial toxins in mice and men: potential regulators of immune cell function. J. Biol. Regul. Homeost. Agents 12, 53-62 (1998)
25. Hamilton CA, Brosnan MJ, McIntyre M, Graham D, Dominiczak AF: Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 37, 529-34 (2001)
26. Heller B, Wang ZQ, Wagner EF, Radons J, Burkle A, Fehsel K, Burkart V, Kolb H: Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J. Biol. Chem. 270, 11176-80 (1995)
27. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T: Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 88, E14-22 (2001)
28. Hoyt DG, Lazo JS: Acute pneumocyte injury, poly(ADP-ribose) polymerase activity, and pyridine nucleotide levels after in vitro exposure of murine lung slices to cyclophosphamide. Biochem. Pharmacol. 48, 1757-65 (1994)
29. Hu Q, Xia Y, Corda S, Zweier JL, Ziegelstein RC: Hydrogen peroxide decreases pH in human aortic endothelial cells by inhibiting Na+/H+ exchange. Circ. Res. 83, 644-51 (1998)
30. Hwang JJ, Choi SY, Koh JY: The role of NADPH oxidase, neuronal nitric oxide synthase and poly(ADP ribose) polymerase in oxidative neuronal death induced in cortical cultures by brain-derived neurotrophic factor and neurotrophin-4/5. J. Neurochem. 82, 894-902 (2002)
31. Ignarro L Ed. (2001): Nitric Oxide - Biology and Pathobiology. Academic Press, New York.
32. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49, 1939-45 (2000)
33. Jagtap P, Soriano FG, Virág L, Liaudet L, Mabley J, Szabó E, Haskó G, Marton A, Lorigados CB, Gallyas F Jr, Sumegi B, Hoyt DG, Baloglu E, VanDuzer J, Salzman AL, Southan GJ, Szabó C: Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit. Care Med. 30, 1071-82 (2002)
34. Janero DR, Hreniuk D, Sharif HM, Prout KC: Hydroperoxide-induced oxidative stress alters pyridine nucleotide metabolism in neonatal heart muscle cells. Am. J. Physiol. 264, C1401-10 (1993)
35. Jijon HB, Churchill T, Malfair D, Wessler A, Jewell LD, Parsons HG, Madsen KL: Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G641-51 (2000)
36. Junod AF, Jornot L, Petersen H: Differential effects of hyperoxia and hydrogen peroxide on DNA damage, polyadenosine diphosphate-ribose polymerase activity, and nicotinamide adenine dinucleotide and adenosine triphosphate contents in cultured endothelial cells and fibroblasts. J. Cell. Physiol. 140, 177-85 (1989)
37. Kennedy M, Denenberg AG, Szabó C, Salzman AL: Poly(ADP-ribose) synthetase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells. Gastroenterology 114, 510-8 (1998)
38. Khan AU, Delude RL, Han YY, Sappington PL, Han X, Carcillo JA, Fink MP: Liposomal NAD(+) prevents diminished O(2) consumption by immunostimulated Caco-2 cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 282, L1082-91 (2002)
39. Kim YH, Koh JY: The role of NADPH oxidase and neuronal nitric oxide synthase in zinc-induced poly(ADP-ribose) polymerase activation and cell death in cortical culture. Exp. Neurol. 177, 407-18 (2002)
40. Kirkland JB: Lipid peroxidation, protein thiol oxidation and DNA damage in hydrogen peroxide-induced injury to endothelial cells: role of activation of poly(ADP-ribose)polymerase. Biochim. Biophys. Acta 1092, 319-25 (1991)
41. Kirsch M, De Groot H: NAD(P)H, a directly operating antioxidant? FASEB J. 15, 1569-74 (2001)
42. Kossenjans W, Rymaszewski Z, Barankiewicz J, Bobst A, Ashraf M: Menadione-induced oxidative stress in bovine heart microvascular endothelial cells. Microcirculation 3, 39-47 (1996)
43. Landmesser U, Hornig B, Drexler H: Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions. Semin. Thromb. Hemost. 26, 529-37 (2000)
44. Lerner F, Niere M, Ludwig A, Ziegler M: Structural and functional characterization of human NAD kinase. Biochem. Biophys. Res. Commun. 288, 69-74 (2001)
45. Li JM, Shah AM: Differential NADPH- versus NADH-dependent superoxide production by phagocyte-type endothelial cell NADPH oxidase. Cardiovasc. Res. 52, 477-86 (2001)
46. Li JM, Shah AM: Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J. Biol. Chem. 277, 19952-60 (2002)
47. Liaudet L, Soriano FG, Szabó E, Virág L, Mabley JG, Salzman AL, Szabó C: Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase. Proc. Natl. Acad. Sci. USA 97, 10203-8 (2000)
48. Magni G, Amici A, Emanuelli M, Raffaelli N, Ruggieri S: Enzymology of NAD+ synthesis. Adv. Enzymol. Relat. Areas Mol. Biol. 73, 135-82 (1999)
49. Matsunaga T, Nakajima T, Miyazaki T, Koyama I, Hokari S, Inoue I, Kawai S, Shimomura H, Katayama S, Hara A, Komoda T: Glycated high-density lipoprotein regulates reactive oxygen species and reactive nitrogen species in endothelial cells. Metabolism 52, 42-9 (2003)
50. Matz RL, Schott C, Stoclet JC, Andriantsitohaina R: Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol. Res. 49, 11-8 (2000)
51. Meyer JW, Schmitt ME: A central role for the endothelial NADPH oxidase in atherosclerosis. FEBS Lett. 472, 1-4 (2000)
52. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, Munzel T: Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90, E58-65 (2002)
53. Moss J, Balducci E, Cavanaugh E, Kim HJ, Konczalik P, Lesma EA, Okazaki IJ, Park M, Shoemaker M, Stevens LA, Zolkiewska A: Characterization of NAD:arginine ADP-ribosyltransferases. Mol. Cell. Biochem. 193, 109-13 (1999)
54. Pacher P, Liaudet L, Mabley J, Komjáti K, Szabo C: Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure. J. Am. Coll. Cardiol. 40, 1006-16 (2002)
55. Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabó E, Szabó C: The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51, 514-21 (2002)
56. Pacher P, Mabley JG, Soriano FG, Liaudet L, Komjáti K, Szabó C: Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation. Br. J. Pharmacol. 135, 1347-50 (2002)
57. Pacher P, Mabley JG, Soriano FG, Liaudet L, Szabó C: Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Int. J. Mol. Med. 9, 659-64 (2002)
58. Pannirselvam M, Verma S, Anderson TJ, Triggle CR: Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: role of decreased tetrahydrobiopterin bioavailability. Br. J. Pharmacol. 136, 255-63 (2002)
59. Parinandi NL, Kleinberg MA, Usatyuk PV, Cummings RJ, Pennathur A, Cardounel AJ, Zweier JL, Garcia JG, Natarajan V: Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L26-38 (2003)
60. Pescarmona GP, Bracone A, David O, Sartori ML, Bosia A: Regulation of NAD and NADP synthesis in human red cell. Acta Biol. Med. Ger. 36, 759-63 (1977)
61. Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG, Cochrane CG: Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J. Clin. Invest. 77, 1312-20 (1986)
62. Shieh WM, Ame JC, Wilson MV, Wang ZQ, Koh DW, Jacobson MK, Jacobson EL: Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymers. J. Biol. Chem. 273, 30069-72 (1998)
63. Sorescu D, Szocs K, Griendling KK: NAD(P)H oxidases and their relevance to atherosclerosis. Trends Cardiovasc Med. 11, 124-31 (2001)
64. Soriano FG, Pacher P, Mabley J, Liaudet L, Szabó C: Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ. Res. 89, 684-91 (2001)
65. Soriano FG, Virág L, Jagtap P, Szabó E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL, Southan GJ, Szabó C: Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat. Med. 7, 108-13 (2001)
66. Soriano FG, Virág L, Szabó C: Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation. J. Mol. Med. 79, 437-48 (2001)
67. Southan GJ, Szabó C: Inhibitors of poly(ADP-ribose) polymerase. Current Med. Chem. (2003) in press
68. Szabo C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL: Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J. Clin. Invest. 100, 723-35 (1997)
69. Szabó C, Dawson VL: Role of poly (ADP-ribose) synthetase activation in inflammation and reperfusion injury. Trends Pharmacol. Sci. 19, 287-98 (1998)
70. Szabó C, Ed (2000): Cell death: the role of PARP. CRC Press, Boca Raton, Florida.
71. Szabó C, Pacher P, Komjati K, Mabley JG, Benko R, Kollai M: Poly(ADP-ribose) polymerase (PARP) activation is an early event in angiotensin-induced cardiovascular disorders. FASEB J. 17: A803 (2003)
72. Szabó C, Virág L, Cuzzocrea S, Scott GS, Hake P, O'Connor MP, Zingarelli B, Salzman A, Kun E: Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc. Natl. Acad. Sci. USA 95, 3867-72 (1998)
73. Szabó C, Zanchi A, Komjati K, Pacher P, Krolewski AS, Quist WC, LoGerfo FW, Horton ES, Veves A: Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 106, 2680-6 (2002)
74. Szabó C, Zingarelli B, O'Connor M, Salzman AL: DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc. Natl. Acad. Sci. USA 93, 1753-8 (1996)
75. Szabó C: PARP as a drug target for the therapy of diabetic cardiovascular dysfunction. Drug News Perspect. 15, 197-205 (2002)
76. Szabó G, Bahrle S, Stumpf N, Sonnenberg K, Szabó E, Pacher P, Csont T, Schulz R, Dengler TJ, Liaudet L, Jagtap PG, Southan GJ, Vahl CF, Hagl S, Szabó C: Poly(ADP-ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ. Res. 90, 100-6 (2002)
77. Takasawa S, Okamoto H: Pancreatic beta-cell death, regeneration and insulin secretion: roles of poly(ADP-ribose) polymerase and cyclic ADP-ribose. Int. J. Exp. Diabetes Res. 3, 79-96 (2002)
78. Terada LS: Oxidative stress and endothelial activation. Crit. Care Med. 30, S186-91 (2002)
79. Thies RL, Autor AP: Reactive oxygen injury to cultured pulmonary artery endothelial cells: mediation by poly(ADP-ribose) polymerase activation causing NAD depletion and altered energy balance. Arch. Biochem. Biophys. 286, 353-63 (1991)
80. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, Quinn MT, Pagano PJ, Johnson C, Alexander RW: Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res. 91, 1160-7 (2002)
81. Valdez LB, Alvarez S, Arnaiz SL, Schopfer F, Carreras MC, Poderoso JJ, Boveris A: Reactions of peroxynitrite in the mitochondrial matrix. Free Radic. Biol. Med. 29, 349-56 (2000)
82. Vallet B, Wiel E: Endothelial cell dysfunction and coagulation. Crit. Care Med. 29, S36-41 (2001)
83. Van Heerebeek L, Meischl C, Stooker W, Meijer CJ, Niessen HW, Roos D: NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? J. Clin. Pathol. 55, 561-8 (2002)
84. Vane JR, Anggard EE, Botting RM: Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323, 27-36 (1990)
85. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, Pritchard KA Jr: Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. USA 95, 9220-5 (1998)
86. Venturini G, Colasanti M, Persichini T, Fioravanti E, Ascenzi P, Palomba L, Cantoni O, Musci G: Beta-amyloid inhibits NOS activity by subtracting NADPH availability. FASEB J. 16, 1970-2 (2002)
87. Virág L, Salzman AL, Szabó C: Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J. Immunol. 161, 3753-9 (1998)
88. Virág L, Scott GS, Antal-Szalmas P, O'Connor M, Ohshima H, Szabó C: Requirement of intracellular calcium mobilization for peroxynitrite-induced poly(ADP-ribose) synthetase activation and cytotoxicity. Mol. Pharmacol. 56, 824-33 (1999)
89. Virág L, Szabó C: BCL-2 protects peroxynitrite-treated thymocytes from poly(ADP-ribose) synthase (PARS)-independent apoptotic but not from PARS-mediated necrotic cell death. Free Radic. Biol. Med. 29, 704-13 (2000)
90. Virág L, Szabó C: Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death. FASEB J. 15, 99-107 (2001)
91. Virág L, Szabó C: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 54, 375-429 (2002)
92. Wattanapitayakul SK, Weinstein DM, Holycross BJ, Bauer JA: Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders. FASEB J. 14, 271-8 (2000)
93. Werner-Felmayer G, Golderer G, Werner ER: Tetrahydrobiopterin biosynthesis, utilization and pharmacological effects. Curr. Drug Metab. 3, 159-73 (2002)
94. Wolf G: Free radical production and angiotensin. Curr. Hypertens. Rep. 2, 167-73 (2000)
95. Yamashiro S, Kuniyoshi Y, Arakaki K, Miyagi K, Koja K: The effect of insufficiency of tetrahydrobiopterin on endothelial function and vasoactivity. Jpn. J. Thorac. Cardiovasc. Surg. 50, 472-7 (2002)
96. Ying W, Chen Y, Alano CC, Swanson RA: Tricarboxylic acid cycle substrates prevent PARP-mediated death of neurons and astrocytes. J. Cereb. Blood Flow Metab. 22, 774-9 (2002)
97. Yu SW, Wang H, Poitra, MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson VL: Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297, 259-63 (2002)
98. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, Diez J: Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 38, 1395-9 (2001)
99. Zhang J, Ed: Therapeutic Implications of PARP Inhibition. CRC Press, Boca Raton, Florida, 2002
100. Ziegler M: New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. Eur. J. Biochem. 267, 1550-64 (2000)
101. Zingarelli B, Salzman AL, Szabó C: Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ. Res. 83, 85-94 (1998)
102. Zulueta JJ, Sawhney R, Yu FS, Cote CC, Hassoun PM: Intracellular generation of reactive oxygen species in endothelial cells exposed to anoxia-reoxygenation. Am. J. Physiol. 272, L897-902 (1997)
103. Zulueta JJ, Yu FS, Hertig IA, Thannickal VJ, Hassoun PM: Release of hydrogen peroxide in response to hypoxia-reoxygenation: role of an NAD(P)H oxidase-like enzyme in endothelial cell plasma membrane. Am. J. Respir. Cell. Mol. Biol. 12, 41-9 (1995)